Eva Martínez-Moragón Selected Research

reslizumab

12/2021

Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eva Martínez-Moragón Research Topics

Disease

14	Asthma (Bronchial Asthma) 12/2023 - 09/2008
2	Inflammation (Inflammations) 09/2021 - 12/2009
1	Osteoporosis 01/2023
1	COVID-19 09/2021
1	Pneumonia (Pneumonitis) 09/2021
1	Eosinophilia 01/2015
1	Dyspnea (Shortness of Breath) 09/2008

Drug/Important Bio-Agent (IBA)

7	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2023 - 05/2012
5	Omalizumab (Xolair)FDA Link 01/2022 - 05/2012
4	Monoclonal AntibodiesIBA 01/2023 - 01/2021
2	benralizumabIBA 09/2023 - 12/2021
2	mepolizumabIBA 01/2023 - 12/2021
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 12/2023
1	reslizumabIBA 12/2021
1	Interleukin-5 (Interleukin 5)IBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 09/2021
1	ApoferritinsIBA 09/2021
1	C-Reactive ProteinIBA 09/2021
1	fibrin fragment D (D-dimer)IBA 09/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2021
1	Methylprednisolone FDA LinkGeneric 09/2021
1	Bronchodilator Agents (Bronchodilators)IBA 01/2015
1	anti-IgE antibodiesIBA 04/2013
1	NitratesIBA 12/2009
1	IsoprostanesIBA 12/2009
1	NitritesIBA 12/2009
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2009
1	Histamine (Histamine Dihydrochloride)FDA Link 09/2008

Therapy/Procedure

3	Therapeutics 01/2023 - 05/2012
2	Biological Therapy 01/2022 - 01/2021
1	Length of Stay 01/2022
1	Drug Tapering 12/2021
1	Dry Powder Inhalers 09/2008